• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Chim Acta . Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications

tetano

Editor, Senior Moderator
Clin Chim Acta


. 2020 Nov 4;S0009-8981(20)30514-3.
doi: 10.1016/j.cca.2020.10.032. Online ahead of print.
Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications


Yanfang Jiang[SUP] 1 [/SUP], Haifeng Wang[SUP] 1 [/SUP], Sijia Hao[SUP] 1 [/SUP], Yukun Chen[SUP] 1 [/SUP], Jiaxue He[SUP] 1 [/SUP], Yong Liu[SUP] 1 [/SUP], Liguo Chen[SUP] 1 [/SUP], Yuanhua Yu[SUP] 2 [/SUP], Shucheng Hua[SUP] 3 [/SUP]



Affiliations

Abstract

The global coronavirus disease 2019 (COVID-19) pandemic has posed great challenges in people's daily lives. Highly sensitive laboratory techniques played a critical role in clinical COVID-19 diagnosis and management. In this study the feasibility of using a new digital PCR-based detection assay for clinical COVID-19 diagnosis was investigated by comparing its performance with that of RT-PCR. Clinical patient samples and samples obtained from potentially contaminated environments were analyzed. The study included 10 patients with confirmed COVID-19 diagnoses, 32 validated samples of various types derived from different clinical timepoints and sites, and 148 environmentally derived samples. SARS-CoV-2 nucleic acids were more readily detected in respiratory tract samples (35.0%). In analyses of environmentally derived samples, the positivity rate of air samples was higher than that of surface samples, probably due to differences in virus concentrations. Digital PCR detected SARS-CoV-2 in several samples that had previously been deemed negative, including 3 patient-derived samples and 5 environmentally derived samples. In this study digital PCR exhibited higher sensitivity than conventional RT-PCR, suggesting that it may be a useful new method for clinical SARS-CoV-2 detection. Improvement of SARS-CoV-2 detection would substantially reduce the rates of false-negative COVID-19 test results, in particular those pertaining to asymptomatic carriers.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; asymptomatic carrier; digital PCR; false-negative results.
 
Back
Top Bottom